Skip to main content
Top
Published in: International Urology and Nephrology 3/2007

01-09-2007 | Original Paper

Body mass index, body fat percentage, and the effect of body fat mass on SWL success

Authors: Ali Ferruh Akay, Abdullah Gedik, Ali Tutus, Hayrettin Şahin, Mehmet Kamuran Bircan

Published in: International Urology and Nephrology | Issue 3/2007

Login to get access

Abstract

Objectives

In the present study, we investigated the effects of the Body Mass Index (BMI), the Body Fat Percentage (BFP), and the Body Fat Mass (BFM) on success of SWL, prospectively.

Patients and methods

The BMI, BFP, BFM values of patients, who were treated by SWL due to upper urinary system stone disease (pelvis renalis, upper ureter, kidney lower and upper calices) between January and December 2005 in our hospital’s urolithiasis center, were measured. Patients with stones smaller than 5 mm or larger than 20 mm and patients who had a stone localized somewhere other than in the upper urinary system, were not included in the study. Patients evaluated to be clinically successful according to the SWL were put in group 1, and the other patients who were not successful were included in group 2.

Results

About 158 (97 male, 61 female) patients aged between 16 and 92 (mean 36.69 (±13.22) years), put on SWL therapy due to presence of upper urinary system stone disease, were included in the study. While the mean BMI was 23.97 ± 0.4 in group 1 and 25.98 ± 0.5 (P = 0.02) in group 2, BFP was 23.85 ± 0.8 in group 1 and 29.19 ± 1.1 (P = 0.001) in group 2, and BFM was determined to be 16.74 ± 0.7 and 21.19 ± 1.01 (P = 0.001) in group 2. Regarding all the parameters (BMI, BFP, BFM), the statistical analyses carried out between the groups showed significant differences.

Conclusion

BFP and BFM parameters are also important factors along with the BMI in providing a successful SWL treatment. All the parameters should be considered regarding the success of the treatment and the patients should be informed.
Literature
1.
go back to reference Mezentsev VA (2005) Extracorporeal shock wave lithotripsy in the treatment of renal pelvicalyceal stones in morbidly obese patients. Int Braz J Urol 31(2):105–110PubMedCrossRef Mezentsev VA (2005) Extracorporeal shock wave lithotripsy in the treatment of renal pelvicalyceal stones in morbidly obese patients. Int Braz J Urol 31(2):105–110PubMedCrossRef
2.
go back to reference Tasan E (2005) Identification, evaluation and epidemiology of obesity. J Int Med Sci 37:1–4 Tasan E (2005) Identification, evaluation and epidemiology of obesity. J Int Med Sci 37:1–4
3.
go back to reference Calvert RC, Burgesl NA (2005) Urolithiasis and obesity: metabolic and technical considerations. Curr Opin Urol 15:113–117PubMedCrossRef Calvert RC, Burgesl NA (2005) Urolithiasis and obesity: metabolic and technical considerations. Curr Opin Urol 15:113–117PubMedCrossRef
4.
go back to reference Paterson RF, Lifshitz DA, Kuo RL, Siqueira TM Jr, Lingeman JE (2002) Shock wave lithotripsy monotherapy for renal calculi. Int Braz J Urol 28(4):291–301PubMed Paterson RF, Lifshitz DA, Kuo RL, Siqueira TM Jr, Lingeman JE (2002) Shock wave lithotripsy monotherapy for renal calculi. Int Braz J Urol 28(4):291–301PubMed
5.
go back to reference World Health Organization Physical Status (1995) The use and interpretation of anthropometry. Technical report series No: 854, Geneva: WHO World Health Organization Physical Status (1995) The use and interpretation of anthropometry. Technical report series No: 854, Geneva: WHO
6.
go back to reference Gurrici S, Hartriyanti Y, Hautvast JG, Deurenberg P (1999) Differences in the relationship between body fat and body mass index between two different Indonesian ethnic groups: the effect of body build. Eur J Clin Nutr 53(6):468–472PubMedCrossRef Gurrici S, Hartriyanti Y, Hautvast JG, Deurenberg P (1999) Differences in the relationship between body fat and body mass index between two different Indonesian ethnic groups: the effect of body build. Eur J Clin Nutr 53(6):468–472PubMedCrossRef
7.
go back to reference Koo BC, Burtt G, Burgess NA (2004) Percutaneous stone surgery in the obese: outcome stratified according to body mass index. BJU Int 93(9):1296–1299PubMedCrossRef Koo BC, Burtt G, Burgess NA (2004) Percutaneous stone surgery in the obese: outcome stratified according to body mass index. BJU Int 93(9):1296–1299PubMedCrossRef
8.
go back to reference Deurenberg P, Yap M (1995 The assessment of obesity: methods for measuring body fat and global prevalence of obesity. Baillieres Best Pract Res Clin Endocrinol Metab 13(1):1–11CrossRef Deurenberg P, Yap M (1995 The assessment of obesity: methods for measuring body fat and global prevalence of obesity. Baillieres Best Pract Res Clin Endocrinol Metab 13(1):1–11CrossRef
9.
go back to reference Pareek G, Armenakas NA, Panagopoulos G, Bruno JJ, Fracchia JA (2005) Extracorporeal shock wave lithotripsy success based on body mass index and Hounsfield units. Urology 65(1):33–36PubMedCrossRef Pareek G, Armenakas NA, Panagopoulos G, Bruno JJ, Fracchia JA (2005) Extracorporeal shock wave lithotripsy success based on body mass index and Hounsfield units. Urology 65(1):33–36PubMedCrossRef
10.
go back to reference Pareek G, Hedican SP, Lee FT Jr, Nakada SY (2005) Shock wave lithotripsy success determined by skin-to-stone distance on computed tomography. Urology 66(5):941–944PubMedCrossRef Pareek G, Hedican SP, Lee FT Jr, Nakada SY (2005) Shock wave lithotripsy success determined by skin-to-stone distance on computed tomography. Urology 66(5):941–944PubMedCrossRef
Metadata
Title
Body mass index, body fat percentage, and the effect of body fat mass on SWL success
Authors
Ali Ferruh Akay
Abdullah Gedik
Ali Tutus
Hayrettin Şahin
Mehmet Kamuran Bircan
Publication date
01-09-2007
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 3/2007
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-006-9133-2

Other articles of this Issue 3/2007

International Urology and Nephrology 3/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.